These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14251318)

  • 21. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of heparin on fibrinogen coagulability].
    VINAZZER H
    Acta Med Scand; 1952 Apr; 142(6):468-75. PubMed ID: 14932814
    [No Abstract]   [Full Text] [Related]  

  • 23. RELEASE OF CARBOHYDRATE FROM FIBRIN MONOMER DURING CLOTTING.
    ROSENBERG A; CARMAN RH
    Nature; 1964 Dec; 204():994-5. PubMed ID: 14248719
    [No Abstract]   [Full Text] [Related]  

  • 24. [PRELIMINARY STUDIES OF THE BLOOD COAGULATION SYSTEM IN UREMIA].
    JUSKOWA J
    Pol Arch Med Wewn; 1964; 34():1183-9. PubMed ID: 14235107
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the chemical compositions of fibrinogen and fibrin. II. Determination of glycide components in the fibrin of normal subjects].
    CHIARIONI T; NARDI E
    Prog Med (Napoli); 1961 Aug; 17():535-9. PubMed ID: 13878907
    [No Abstract]   [Full Text] [Related]  

  • 26. [DYNAMIC STUDIES ON BLOOD COAGULATION IN SURGICALLY TREATED AGED SUBJECTS].
    ATANASOV A; MARINOV V; TARULOV S
    Khirurgiia (Sofiia); 1964; 17():193-4. PubMed ID: 14149066
    [No Abstract]   [Full Text] [Related]  

  • 27. STUDIES ON THE PHYSIOLOGICAL ACTIVITY OF THE PEPTIDE RELEASED DURING THE FIBRINOGEN-FIBRIN CONVERSION.
    OSBAHR AJ; GLADNER JA; LAKI K
    Biochim Biophys Acta; 1964 Jun; 86():535-42. PubMed ID: 14192905
    [No Abstract]   [Full Text] [Related]  

  • 28. [USE OF A PHOTOMETRIC METHOD FOR THE STUDY OF COAGULATION AND FIBRINOLYSIS].
    GRUENDLINGER J; BOUVIER CA
    Thromb Diath Haemorrh; 1964 Dec; 12():423-51. PubMed ID: 14254702
    [No Abstract]   [Full Text] [Related]  

  • 29. [The structure and role of the sugar moiety of fibrinogen and fibrin: On the bonding of sugar compounds].
    MESTER L; MOCZAR E; LAKI K
    C R Hebd Seances Acad Sci; 1963 Jan; 256():307-8. PubMed ID: 13935150
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of carryover of clot activators on coagulation tests during phlebotomy.
    Fukugawa Y; Ohnishi H; Ishii T; Tanouchi A; Sano J; Miyawaki H; Kishino T; Ohtsuka K; Yoshino H; Watanabe T
    Am J Clin Pathol; 2012 Jun; 137(6):900-3. PubMed ID: 22586048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A haemorrhagic disorder in pregnancy due to an "anticoagulant" preventing the conversion of fibrinogen to fibrin.
    BAKER SJ; JACOB E
    J Clin Pathol; 1960 May; 13(3):214-9. PubMed ID: 13796035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [LEUKOCYTE FACTORS IN BLOOD COAGULATION OF PATIENTS WITH EXACERBATION OF CHRONIC MYELOSIS].
    KUZNIK BI; ALNIKOV GP
    Probl Gematol Pereliv Krovi; 1964 Jan; 9():20-4. PubMed ID: 14162652
    [No Abstract]   [Full Text] [Related]  

  • 33. Protein composition of clots detected in pooled cryoprecipitate units.
    MacPhee M; Wilmer B; Beall D; Moroff G
    Transfusion; 2013 Mar; 53(3):651-4. PubMed ID: 22804740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of carboxypeptidase N to fibrinogen and fibrin.
    Talens S; Lebbink JH; Malfliet JJ; Demmers JA; Uitte de Willige S; Leebeek FW; Rijken DC
    Biochem Biophys Res Commun; 2012 Oct; 427(2):421-5. PubMed ID: 23000409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
    Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A.
    Sherman LA; Gaston LW; Kaplan ME; Spivack AR
    J Clin Invest; 1972 Mar; 51(3):590-7. PubMed ID: 4622105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect, in the presence and absence of ionized calcium, of certain antagonists of the thrombin conversion of fibrinogen].
    BURSTEIN M
    Arch Int Pharmacodyn Ther; 1951 Feb; 85(3-4):467-73. PubMed ID: 14830360
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects on fibrinogen, fibrin, and blood coagulation of proteolytic extracts from fruits of Pseudananas macrodontes, Bromelia balansae, and B. hieronymi (Bromeliaceae) in comparison with bromelain.
    Errasti ME; Prospitti A; Viana CA; Gonzalez MM; Ramos MV; Rotelli AE; Caffini NO
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):441-9. PubMed ID: 26886361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply to: Comparing the visco-elastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one? By Schöchl et al.
    Prüller F; Mangge H
    Clin Chem Lab Med; 2016 Sep; 54(9):e277. PubMed ID: 27394045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.